[
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Higher Late Afternoon",
    "summary": "Health care stocks rose late Monday afternoon with the NYSE Health Care Index up 0.4% and the Health",
    "url": "https://finnhub.io/api/news?id=904ce749689e3d6f87f1afa1da608abadbd5320b37798fa02fc43b0fcd295595",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751313385,
      "headline": "Sector Update: Health Care Stocks Higher Late Afternoon",
      "id": 135676896,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Health care stocks rose late Monday afternoon with the NYSE Health Care Index up 0.4% and the Health",
      "url": "https://finnhub.io/api/news?id=904ce749689e3d6f87f1afa1da608abadbd5320b37798fa02fc43b0fcd295595"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Advance Monday Afternoon",
    "summary": "Health care stocks rose Monday afternoon with the NYSE Health Care Index climbing 0.2% and the Healt",
    "url": "https://finnhub.io/api/news?id=689102be9f16142682ef3874bdaf9485ab2e814095819d3a9faf2330bf1cccff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751305744,
      "headline": "Sector Update: Health Care Stocks Advance Monday Afternoon",
      "id": 135671101,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Health care stocks rose Monday afternoon with the NYSE Health Care Index climbing 0.2% and the Healt",
      "url": "https://finnhub.io/api/news?id=689102be9f16142682ef3874bdaf9485ab2e814095819d3a9faf2330bf1cccff"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Up as Budget Bill Fears Ease -- Health Care Roundup",
    "summary": "Health-care companies rose, shrugging off some recent weakness associated with proposals in the Republican tax-and-budget bill. One strategist noted that the health-care sector has been among the...",
    "url": "https://finnhub.io/api/news?id=997953aa57aad52e9c2f6a167c5e7cc6982debf10448ada4924898bc52e84aa7",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751304668,
      "headline": "Health Care Up as Budget Bill Fears Ease -- Health Care Roundup",
      "id": 135675781,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Health-care companies rose, shrugging off some recent weakness associated with proposals in the Republican tax-and-budget bill. One strategist noted that the health-care sector has been among the...",
      "url": "https://finnhub.io/api/news?id=997953aa57aad52e9c2f6a167c5e7cc6982debf10448ada4924898bc52e84aa7"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Inc.(NasdaqGS: MRNA) added to Russell Midcap Value Index",
    "summary": "Moderna, Inc. added to Russell Midcap Value Index...",
    "url": "https://finnhub.io/api/news?id=d13e6d6a6dbad59d1724b80548967385d64caad428d6f0294e306dcdc053deb6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751303206,
      "headline": "Moderna, Inc.(NasdaqGS: MRNA) added to Russell Midcap Value Index",
      "id": 135675473,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna, Inc. added to Russell Midcap Value Index...",
      "url": "https://finnhub.io/api/news?id=d13e6d6a6dbad59d1724b80548967385d64caad428d6f0294e306dcdc053deb6"
    }
  },
  {
    "ts": null,
    "headline": "Moderna’s mRNA flu shot outperforms current standard at Phase III",
    "summary": "The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.",
    "url": "https://finnhub.io/api/news?id=c6fbe356e33de7fefdeb2a60c000a0952058201d23e233964070f90f5a592a2a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751301630,
      "headline": "Moderna’s mRNA flu shot outperforms current standard at Phase III",
      "id": 135672431,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.",
      "url": "https://finnhub.io/api/news?id=c6fbe356e33de7fefdeb2a60c000a0952058201d23e233964070f90f5a592a2a"
    }
  },
  {
    "ts": null,
    "headline": "Did Down-And-Out Moderna Just Unlock The Key To Its Future Profitability?",
    "summary": "Did Down-And-Out Moderna Just Unlock The Key To Its Future Profitability?",
    "url": "https://finnhub.io/api/news?id=ac8a7621f8e45b2e742dba9b76ed253f84c9b47acf6935b545dd6f340f462359",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751300828,
      "headline": "Did Down-And-Out Moderna Just Unlock The Key To Its Future Profitability?",
      "id": 135991817,
      "image": "",
      "related": "MRNA",
      "source": "DowJones",
      "summary": "Did Down-And-Out Moderna Just Unlock The Key To Its Future Profitability?",
      "url": "https://finnhub.io/api/news?id=ac8a7621f8e45b2e742dba9b76ed253f84c9b47acf6935b545dd6f340f462359"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Is Climbing on Trial Data. A Flu-Covid Vaccine Isn’t a Sure Thing.",
    "summary": "An influenza vaccine candidate from  Moderna  showed promising results in a late-stage trial, bringing the drug maker one step closer to producing a combined flu-and-Covid shot.  Moderna  said its seasonal flu vaccine candidate, mRNA-1010, showed “positive results” in a Phase 3 efficacy study comparing it with a licensed standard-dose seasonal flu vaccine.  In participants aged 65 years and older, mRNA-1010 had a relative vaccine efficacy rate of 27.4%, Moderna said.",
    "url": "https://finnhub.io/api/news?id=e70ec53a9ba74df8ba8a5b69adf63da0d15f09f4b5f48d90047726146461c1ef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751299560,
      "headline": "Moderna Stock Is Climbing on Trial Data. A Flu-Covid Vaccine Isn’t a Sure Thing.",
      "id": 135666517,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "An influenza vaccine candidate from  Moderna  showed promising results in a late-stage trial, bringing the drug maker one step closer to producing a combined flu-and-Covid shot.  Moderna  said its seasonal flu vaccine candidate, mRNA-1010, showed “positive results” in a Phase 3 efficacy study comparing it with a licensed standard-dose seasonal flu vaccine.  In participants aged 65 years and older, mRNA-1010 had a relative vaccine efficacy rate of 27.4%, Moderna said.",
      "url": "https://finnhub.io/api/news?id=e70ec53a9ba74df8ba8a5b69adf63da0d15f09f4b5f48d90047726146461c1ef"
    }
  },
  {
    "ts": null,
    "headline": "Top Stock Movers Now: Hewlett Packard Enterprise, Moderna, Tesla, and More",
    "summary": "The S&P 500 and Nasdaq added to their all-time highs at midday as investors anticipated more U.S. trade agreements ahead.",
    "url": "https://finnhub.io/api/news?id=3f4ee2c82b0cbcf8ccad84e88e4c283e6d07e4ded7a0d09ef879f3508063e73f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751299060,
      "headline": "Top Stock Movers Now: Hewlett Packard Enterprise, Moderna, Tesla, and More",
      "id": 135663768,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The S&P 500 and Nasdaq added to their all-time highs at midday as investors anticipated more U.S. trade agreements ahead.",
      "url": "https://finnhub.io/api/news?id=3f4ee2c82b0cbcf8ccad84e88e4c283e6d07e4ded7a0d09ef879f3508063e73f"
    }
  },
  {
    "ts": null,
    "headline": "Top Midday Stories: Hewlett Packard, Juniper Settle Antitrust Suit With DOJ; Home Depot Unit Acquires GMS for $5.5 Billion",
    "summary": "All three major US stock indexes were up in late-morning trading Monday after Canada announced late",
    "url": "https://finnhub.io/api/news?id=e4cfa381cf82b99f0a852c2cc82ac52c026229316182b361b1003c05ef96bec3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751297858,
      "headline": "Top Midday Stories: Hewlett Packard, Juniper Settle Antitrust Suit With DOJ; Home Depot Unit Acquires GMS for $5.5 Billion",
      "id": 135663770,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "All three major US stock indexes were up in late-morning trading Monday after Canada announced late",
      "url": "https://finnhub.io/api/news?id=e4cfa381cf82b99f0a852c2cc82ac52c026229316182b361b1003c05ef96bec3"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Shares Jump With Positive Test Results for MRNA Flu Vaccine",
    "summary": "The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.",
    "url": "https://finnhub.io/api/news?id=56991892f58778bdb24229fbb55d01acece1ea7e08105def181f7a0f720570a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751294280,
      "headline": "Moderna Shares Jump With Positive Test Results for MRNA Flu Vaccine",
      "id": 135672435,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.",
      "url": "https://finnhub.io/api/news?id=56991892f58778bdb24229fbb55d01acece1ea7e08105def181f7a0f720570a8"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Says Flu Vaccine Candidate More Effective Than Standard Licensed Shots",
    "summary": "Moderna (MRNA) said Monday that late-stage trial data showed its experimental flu vaccine was more e",
    "url": "https://finnhub.io/api/news?id=0dfd8cf6bef674bb274c46b5fbc7f504cbf99baf4ff29b3cf801ff96812ab7d2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751294107,
      "headline": "Moderna Says Flu Vaccine Candidate More Effective Than Standard Licensed Shots",
      "id": 135672436,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (MRNA) said Monday that late-stage trial data showed its experimental flu vaccine was more e",
      "url": "https://finnhub.io/api/news?id=0dfd8cf6bef674bb274c46b5fbc7f504cbf99baf4ff29b3cf801ff96812ab7d2"
    }
  },
  {
    "ts": null,
    "headline": "Stocks See Support as Signs of Trade Progress Boost Market Sentiment",
    "summary": "The S&P 500 Index ($SPX ) (SPY ) today is up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.38%. September E-mini S&P futures (ESU25 ) are up +0.27%, and September E-mini Nasdaq futures...",
    "url": "https://finnhub.io/api/news?id=9ab2f61b8204611f3da61139c7ba1a70abd25e74770215c53709d4e7f27414a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751292476,
      "headline": "Stocks See Support as Signs of Trade Progress Boost Market Sentiment",
      "id": 135661457,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The S&P 500 Index ($SPX ) (SPY ) today is up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.38%. September E-mini S&P futures (ESU25 ) are up +0.27%, and September E-mini Nasdaq futures...",
      "url": "https://finnhub.io/api/news?id=9ab2f61b8204611f3da61139c7ba1a70abd25e74770215c53709d4e7f27414a1"
    }
  },
  {
    "ts": null,
    "headline": "Solar stocks, Moderna, HPE: Trending Tickers",
    "summary": "Solar stocks such as Enphase (ENPH), SunRun (RUN), and SolarEdge (SEDG) are in focus as changes to the big beautiful bill could introduce new taxes on the industry. Moderna (MRNA) sees promising drug trial results for its combination flu shot and COVID-19 vaccine. HPE (HPE) has reached a settlement with the Department of Justice to allow it to proceed with its $14 billion acquisition of Juniper Networks (JNPR). Check out Yahoo Finance's interview with HPE CEO Antonio Neri here. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=21ff75898667b8350eb19e1c5bee63e91bce02cad2f71bab10797f9cb310dc63",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751290691,
      "headline": "Solar stocks, Moderna, HPE: Trending Tickers",
      "id": 135662966,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Solar stocks such as Enphase (ENPH), SunRun (RUN), and SolarEdge (SEDG) are in focus as changes to the big beautiful bill could introduce new taxes on the industry. Moderna (MRNA) sees promising drug trial results for its combination flu shot and COVID-19 vaccine. HPE (HPE) has reached a settlement with the Department of Justice to allow it to proceed with its $14 billion acquisition of Juniper Networks (JNPR). Check out Yahoo Finance's interview with HPE CEO Antonio Neri here. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=21ff75898667b8350eb19e1c5bee63e91bce02cad2f71bab10797f9cb310dc63"
    }
  },
  {
    "ts": null,
    "headline": "Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Monday Amid Hopes of Smoother Canada Relations",
    "summary": "The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.5% and the actively trad",
    "url": "https://finnhub.io/api/news?id=3dbf8838f0f71ffd075492f4c0c081a5a74def7b1db1aa682246ebc4eae94529",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751287503,
      "headline": "Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Monday Amid Hopes of Smoother Canada Relations",
      "id": 135652293,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.5% and the actively trad",
      "url": "https://finnhub.io/api/news?id=3dbf8838f0f71ffd075492f4c0c081a5a74def7b1db1aa682246ebc4eae94529"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Down Around 9% in Three Months: Should You Buy, Sell or Hold the Stock?",
    "summary": "VRTX slips 9% in three months on slow new drug uptake and pipeline hiccups, but CF strength and 2025 growth offer a reason to hold.",
    "url": "https://finnhub.io/api/news?id=eee75656e22e9516b0e2eb08630014ff6c43cf937de27626bd9fb7712c573b0d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751286600,
      "headline": "Vertex Down Around 9% in Three Months: Should You Buy, Sell or Hold the Stock?",
      "id": 135671797,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "VRTX slips 9% in three months on slow new drug uptake and pipeline hiccups, but CF strength and 2025 growth offer a reason to hold.",
      "url": "https://finnhub.io/api/news?id=eee75656e22e9516b0e2eb08630014ff6c43cf937de27626bd9fb7712c573b0d"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine",
    "summary": "mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older CAMBRIDGE, MA / ACCESS Newswire / June 30, 2025 / Moderna, ...",
    "url": "https://finnhub.io/api/news?id=de75fd634d68a7348d7c917798dddbd60e266d2a66e28918bba99b7c82424427",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751281200,
      "headline": "Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine",
      "id": 135672442,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older CAMBRIDGE, MA / ACCESS Newswire / June 30, 2025 / Moderna, ...",
      "url": "https://finnhub.io/api/news?id=de75fd634d68a7348d7c917798dddbd60e266d2a66e28918bba99b7c82424427"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: positive efficacy data for influenza",
    "summary": "Moderna reports positive results from a Phase 3 P304 efficacy study evaluating its investigational seasonal influenza vaccine mRNA-1010 compared to a standard-dose seasonal influenza vaccine in adults...",
    "url": "https://finnhub.io/api/news?id=d6f887adb2ef04399eb617870509558d7cf42b186f39f709354013b6f9ea8564",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751273430,
      "headline": "Moderna: positive efficacy data for influenza",
      "id": 135651510,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna reports positive results from a Phase 3 P304 efficacy study evaluating its investigational seasonal influenza vaccine mRNA-1010 compared to a standard-dose seasonal influenza vaccine in adults...",
      "url": "https://finnhub.io/api/news?id=d6f887adb2ef04399eb617870509558d7cf42b186f39f709354013b6f9ea8564"
    }
  },
  {
    "ts": null,
    "headline": "Moderna says flu shot more effective than rival GSK in late-stage study",
    "summary": "Moderna said on Monday itsinfluenza vaccine was found to be 26.6% more effective than anapproved annual flu shot from GSK in adults aged 50years and older in a late-stage study, sending its shares...",
    "url": "https://finnhub.io/api/news?id=9efd2d1de74254fa0dd2e266f24e15b89b59996e9af7c32d3b716b2dbc6c60a6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751267790,
      "headline": "Moderna says flu shot more effective than rival GSK in late-stage study",
      "id": 135652710,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna said on Monday itsinfluenza vaccine was found to be 26.6% more effective than anapproved annual flu shot from GSK in adults aged 50years and older in a late-stage study, sending its shares...",
      "url": "https://finnhub.io/api/news?id=9efd2d1de74254fa0dd2e266f24e15b89b59996e9af7c32d3b716b2dbc6c60a6"
    }
  },
  {
    "ts": null,
    "headline": "Moderna's experimental flu vaccine more effective than approved shot in study",
    "summary": "Moderna said on Monday itsexperimental influenza vaccine was found to be 26.6% moreeffective than a currently approved annual flu shot when testedin adults aged 50 years and older in a late-stage...",
    "url": "https://finnhub.io/api/news?id=8bd4699b403435f985f89ab6857c2502c4f46c0ec1f9e74ece6c852b26a5a176",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751267790,
      "headline": "Moderna's experimental flu vaccine more effective than approved shot in study",
      "id": 135650561,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna said on Monday itsexperimental influenza vaccine was found to be 26.6% moreeffective than a currently approved annual flu shot when testedin adults aged 50 years and older in a late-stage...",
      "url": "https://finnhub.io/api/news?id=8bd4699b403435f985f89ab6857c2502c4f46c0ec1f9e74ece6c852b26a5a176"
    }
  },
  {
    "ts": null,
    "headline": "Moderna's influenza vaccine superior to licensed shot in study",
    "summary": "Moderna said itsexperimental influenza vaccine showed superior efficacy comparedwith a licensed standard-dose seasonal flu shot in adults aged50 years and older in a late-stage study. ...",
    "url": "https://finnhub.io/api/news?id=fe09f96127f6bd782f17ce67100cb4a095f4a3c429757e0788f3dd9d57746d49",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751267790,
      "headline": "Moderna's influenza vaccine superior to licensed shot in study",
      "id": 135649947,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna said itsexperimental influenza vaccine showed superior efficacy comparedwith a licensed standard-dose seasonal flu shot in adults aged50 years and older in a late-stage study. ...",
      "url": "https://finnhub.io/api/news?id=fe09f96127f6bd782f17ce67100cb4a095f4a3c429757e0788f3dd9d57746d49"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Inc.(NasdaqGS: MRNA) dropped from Russell Top 200 Value Index",
    "summary": "Moderna, Inc. dropped from Russell Top 200 Value Index...",
    "url": "https://finnhub.io/api/news?id=ad7052640c0b21da6c28ad91123aa86c1b8655ed15193779aa083cfd1ea3f2d2",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751251953,
      "headline": "Moderna, Inc.(NasdaqGS: MRNA) dropped from Russell Top 200 Value Index",
      "id": 135640899,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna, Inc. dropped from Russell Top 200 Value Index...",
      "url": "https://finnhub.io/api/news?id=ad7052640c0b21da6c28ad91123aa86c1b8655ed15193779aa083cfd1ea3f2d2"
    }
  }
]